| 1 |
Valero C, Ganly I. Paragangliomas of the head and neck [J]. J Oral Pathol Med, 2022, 18.
|
| 2 |
Leonetti JP. Neurological manifestations of paragangliomas of the head and neck [J]. Curr Neurol Neurosci Rep, 2022, 22(8): 485-489.
|
| 3 |
Cleere EF, Martin-Grace J, Gendre A, et al. Contemporary management of paragangliomas of the head and neck [J]. Laryngoscope Investig Otolaryngol, 2021, 7(1): 93-107.
|
| 4 |
Mete O, Wenig BM. Update from the 5th Edition of the World Health Organization classification of head and neck tumors: overview of the 2022 WHO classification of head and neck neuroendocrine neoplasms [J]. Head Neck Pathol, 2022, 16(1): 123-142.
|
| 5 |
Shamblin WR, ReMine WH, Sheps SG, et al. Carotid body tumor (chemodectoma). Clinicopathologic analysis of ninety cases [J]. Am J Surg, 1971, 122(6): 732-739.
|
| 6 |
Wang YH, Zhu JH, Yang J, et al. The characteristics of carotid body tumors in high-altitude region: Analysis from a single center [J]. Vascular, 2022, 30(2): 301-309.
|
| 7 |
Bryant JP, Wang S, Niazi T. Carotid Body Tumor Microenvironment [J]. Adv Exp Med Biol, 2020, 1296: 151-162.
|
| 8 |
Mohebali J, Edwards HA, Schwartz SI, et al. Multispecialty surgical management of carotid body tumors in the modern era [J]. J Vasc Surg, 2021, 73(6): 2036-2040.
|
| 9 |
Fathalla AE, Elalfy MA. Clinical outcome of carotid body paraganglioma management: a review of 10-year experience [J]. J Oncol, 2020, 2020: 6081273.
|
| 10 |
Unlü Y, Becit N, Ceviz M, et al. Management of carotid body tumors and familial paragangliomas: review of 30 years' experience [J]. Ann Vasc Surg, 2009, 23(5): 616-620.
|
| 11 |
Gonzalez-Urquijo M, Viteri-Pérez VH, Becerril-Gaitan A, et al. Clinical characteristics and surgical outcomes of carotid body tumors: data from the carotid paraganglioma cooperative international registry (CAPACITY) group [J]. World J Surg, 2022, 46(10): 2507-2514.
|
| 12 |
Kimura N, Takekoshi K, Naruse M. Risk stratification on pheochromocytoma and paraganglioma from laboratory and clinical medicine [J]. J Clin Med, 2018, 7(9): 242.
|
| 13 |
Prasad SC, Laus M, Al-Ghamdi S, et al. Update in the classification and the role of intra-arterial stenting in the management of carotid body paragangliomas [J]. Head Neck, 2019, 41(5): 1379-1386.
|
| 14 |
Liu J, Mu H, Zhang W. Diagnosis and treatment of carotid body tumors [J]. Am J Transl Res, 2021, 13(12): 14121-14132.
|
| 15 |
Cobb AN, Barkat A, Daungjaiboon W, et al. Carotid body tumor resection: Just as safe without preoperative embolization [J]. Ann Vasc Surg, 2020, 64: 163-168.
|
| 16 |
DuBois J, Kelly W, McMenamin P, et al. Bilateral carotid body tumors managed with preoperative embolization: a case report and review [J]. J Vasc Surg, 1987, 5(4): 648-650.
|
| 17 |
Paolucci A, Ierardi AM, Hohenstatt S, et al. Pre-surgical embolization of carotid body paragangliomas: advantages of direct percutaneous approach and transitory balloon-occlusion at the origin of the external carotid artery [J]. Radiol Med, 2022, 127(4): 433-439.
|
| 18 |
Wernick BD, Furlough CL, Patel U, et al. Contemporary management of carotid body tumors in a Midwestern academic center [J]. Surgery, 2021, 169(3): 700-704.
|
| 19 |
Li N, Zeng N, Wan Y, et al. The earlier, the better: the beneficial effect of different timepoints of the preoperative transarterial embolization on ameliorating operative blood loss and operative time for carotid body tumors [J]. Surgery, 2021, 170(5): 1581-1585.
|
| 20 |
Texakalidis P, Charisis N, Giannopoulos S, et al. Role of preoperative embolization in carotid body tumor surgery: a systematic review and meta-analysis [J]. World Neurosurg, 2019, 129: 503-513.e2.
|
| 21 |
Katagiri K, Shiga K, Ikeda A, et al. The influence of young age on difficulties in the surgical resection of carotid body tumors [J]. Cancers (Basel), 2021, 13(18): 4565.
|
| 22 |
Metheetrairut C, Chotikavanich C, Keskool P, et al. Carotid body tumor: a 25-year experience [J]. Eur Arch Otorhinolaryngol, 2016, 273(8): 2171-2179.
|
| 23 |
Zhang W, Liu F, Hou K, et al. Surgical outcomes and factors associated with malignancy in carotid body tumors [J]. J Vasc Surg, 2021, 74(2): 586-591.
|
| 24 |
Zhang WC, Cheng JP, Li Q, et al. Clinical and pathological analysis of malignant carotid body tumour: a report of nine cases [J]. Acta Otolaryngol, 129(11): 1320-1325.
|
| 25 |
Alshamsan B, Atallah JP. Durable response to pazopanib in recurrent metastatic carotid body paraganglioma [J]. Case Rep Oncol, 2020, 13(3): 1227-1231.
|
| 26 |
Mete O, Wenig BM. Update from the 5th Edition of the World Health Organization Classification of head and neck tumors: overview of the 2022 WHO classification of head and neck neuroendocrine neoplasms [J]. Head Neck Pathol, 16(1): 123-142.
|
| 27 |
Mascia D, Esposito G, Ferrante A, et al. Carotid body tumor contemporary management in a high-volume center. J Cardiovasc Surg (Torino). 2020 Aug;61(4):459-466.
|
| 28 |
Suárez C, Rodrigo JP, Mendenhall WM, et al. Carotid body paragangliomas: a systematic study on management with surgery and radiotherapy [J]. Eur Arch Otorhinolaryngol, 2014, 271(1): 23-34.
|
| 29 |
Fatima N, Pollom E, Soltys S, et al. Stereotactic radiosurgery for head and neck paragangliomas: a systematic review and meta-analysis [J]. Neurosurg Rev, 2021, 44(2): 741-752.
|